• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.

作者信息

Asahi Hideki, Mizokami Atushi, Maeda Yuji, Komatsu Kazuto, Koshida Kiyoshi, Namiki Mikio

机构信息

Yatsuo General Hospital, Toyama, Japan.

出版信息

J Urol. 2003 Jan;169(1):281-2. doi: 10.1016/S0022-5347(05)64093-1.

DOI:10.1016/S0022-5347(05)64093-1
PMID:12478161
Abstract
摘要

相似文献

1
Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.双膦酸盐疗法用于治疗伴有骨转移的激素难治性前列腺癌。
J Urol. 2003 Jan;169(1):281-2. doi: 10.1016/S0022-5347(05)64093-1.
2
Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.唑来膦酸对耐紫杉烷、雌莫司汀、卡铂和地塞米松的转移性激素难治性前列腺癌的作用。
Int J Urol. 2007 Jan;14(1):82-4. doi: 10.1111/j.1442-2042.2006.01566.x.
3
Resistance to gonadotropin-releasing hormone agonist in a patient with metastatic prostate cancer.一名转移性前列腺癌患者对促性腺激素释放激素激动剂产生耐药性。
South Med J. 1997 Apr;90(4):460-1. doi: 10.1097/00007611-199704000-00025.
4
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.多西他赛、磷酸雌莫司汀和唑来膦酸联合治疗雄激素非依赖性转移性前列腺癌：疗效、安全性及临床获益评估
Urology. 2005 Jan;65(1):126-30. doi: 10.1016/j.urology.2004.08.041.
5
Penile metastasis of prostatic adenocarcinoma.前列腺腺癌的阴茎转移
Int J Urol. 2002 Oct;9(10):597-8. doi: 10.1046/j.1442-2042.2002.00518.x.
6
Assessment of response to carboplatin in patients with hormone-refractory prostate cancer: a critical analysis of drug activity.
Anticancer Res. 1995 Nov-Dec;15(6B):2825-8.
7
Long-term response to combination therapy with estramustine and somatostatin analogue in a patient with androgen ablation-refractory prostate cancer.
Urology. 2004 Dec;64(6):1231.e1-3. doi: 10.1016/j.urology.2004.06.066.
8
Renal toxicity following zoledronic acid reversed with ibandronate in a prostate cancer patient with bone metastases.
Urol Int. 2008;80(4):448-50. doi: 10.1159/000132707. Epub 2008 Jun 27.
9
Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis.基线骨标志物对激素敏感性前列腺癌骨转移患者疾病进展和生存的意义
World J Urol. 2015 Sep;33(9):1263-8. doi: 10.1007/s00345-014-1431-1. Epub 2014 Oct 30.
10
A transient increase in serum procollagen 1 carboxyterminal peptide following effective treatment in prostate cancer patients with bone metastases.在患有骨转移的前列腺癌患者接受有效治疗后，血清前胶原1羧基末端肽短暂升高。
Urol Int. 1997;58(4):236-8. doi: 10.1159/000282991.

引用本文的文献

1
Inhibition of growth and migration of cholangiocarcinoma cells by pamidronate.帕米膦酸盐对胆管癌细胞生长和迁移的抑制作用
Exp Ther Med. 2019 Nov;18(5):3977-3983. doi: 10.3892/etm.2019.8041. Epub 2019 Sep 23.
2
The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.前列腺癌继发脊柱转移中破骨细胞与成骨细胞的相互作用。
Cancer Growth Metastasis. 2013 Nov 27;6:61-80. doi: 10.4137/CGM.S12769. eCollection 2013.